?
1.Date of occurrence of the event:2026/06/26 2.Cause of occurrence:Announced as required by the TPEx 3.Financial and business information: NT$ million (1) Monthly May 2026 May 2025
1.Date of the resolution by the board of directors or shareholders’ meeting, or of the decision by the company:2026/06/17 2.Type (ex-rights or ex-dividend) (please write ”Ex-rights”, ”Ex-dividend”, or ”Ex-rights and dividend”):Ex-dividend 3.Type and monetary amount of common stock dividend distribution:Cash dividends totaling NTD 337,060,200 will be distributed, equivalent
1.Date of the shareholders' meeting resolution:2026/06/17 2.Name and title of the managerial officer with permission to engage in competitive conduct: (1)Maggie Chang; Director (Representative of Liu Handa Holdings, LLC) (2)Toshiyo Chen; Director (Representative of Liu Handa Holdings, LLC) (3)Willie Lin; Director (Representative of Liu Handa Holdings, LLC) (4)Jo Shen; Director (5)James
1.Date of the shareholders' meeting:2026/06/17 2.Important resolutions I.Profit distribution/deficit compensation:Acknowledgement of the distribution of earnings for fiscal year 2025. 3.Important resolutions II.Amendments of the company charter:Approved the amendment to certain provisions of the Articles of Incorporation. 4.Important resolutions III.Business report and financial statements: Acknowledgement of the 2025 Business
1.Originally prescribed ceiling on total monetary amount of share repurchase (NTD):3,724,664,099 2.Originally scheduled period for the repurchase:2026/04/17~2026/06/16 3.Originally determined no.of shares to be repurchased (shares):4,000,000 4.Originally determined repurchase price range (NTD):70.00~109.00, should the Company’s share price fall below the lower limit of the trading range, share repurchases will
1.Date the cumulative no.of shares currently repurchased accounted for 2 percent or more of the shares issued by the company, or amounted to NT$300 million or more:2026/06/10 2.No.of shares currently repurchased (shares):3,406,000 3.Type of shares currently repurchased:Common shares 4.Total monetary amount of shares currently repurchased (NTD):254,216,634 5.Current average repurchase price per
1.Date of the competent authority’s approval of capital reduction:2026/05/21 2.Date of completion of capitalization change registration:2026/05/21 3.Effect on the financial statements (including any discrepancy between the amount of paid-in capital and the no.of shares outstanding, and the effect on net worth per share): (1)Before the cancellation of restricted employee
1.Date of occurrence of the event: 2026/05/11 2.Company name: Handa Pharmaceuticals, Inc. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”): Head office 4.Reciprocal shareholding ratios: NA. 5.Name of the reporting media: Economic Daily News 6.Content of the report: According to market analysts ……The market estimates that Handa’s EPS
1.Date of the board of directors resolution:2026/05/07 2.Name and title of the managerial officer with permission to engage in competitive conduct: Emi Yang/Vice President 3.Items of competitive conduct in which the officer is permitted to engage: Director of Haniverse Pharmaceuticals Limited 4.Period of permission to engage in the
1.Date of the board of directors resolution:2026/02/11 2.Purpose of the share repurchase:To transfer shares to employees 3.Type of shares to be repurchased:Common shares 4.Ceiling on total monetary amount of share repurchase (NTD):3,087,249,414 5.Scheduled period for the repurchase:2026/02/12~2026/04/11 6.No.of shares to be repurchased (shares):2,000,000 7.Repurchase price range (NTD):80.00~120.00, should the Company’s share